Lexicon Pharmaceuticals Inc
![Lexicon Pharmaceuticals Inc](https://api.admiralmarkets.com/trade_icons/bright-128/LXRX.png)
Closed
Sector Healthcare
1.6
Overview
Share price change
24h
Min
1.6
Max
1.61
Income | -51M |
---|---|
Sales | 540K 702K |
EPS | -0.2 |
Profit margin | -31,188.272 |
Employees | 285 |
EBITDA | -49M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +417.39 upside |
Market Cap | -1.2M 510M |
---|---|
Previous open | 1.6 |
Previous close | 1.6 |
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Lexicon Pharmaceuticals Inc Chart
Related News
Peer Comparison
Price change
Lexicon Pharmaceuticals Inc Forecast
Price Target
By TipRanks
417.39% upside
12 Months Forecast
Average 8.33 USD 417.39%
High 10 USD
Low 5 USD
Based on 4 Wall Street analysts offering 12 month price targets forLexicon Pharmaceuticals Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of treatments for human diseases. The Company's drug programs include Sotagliflozin, LX9211 and LX2761. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of type I diabetes and type II diabetes, heart failure and chronic kidney disease. LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of sodium-glucose cotransporter 2 (SGLT2) in the kidney.